In the face of increasing bacterial drug resistance because of β-lactamase production, many microbial infections can be treated effectively by combining clavulanic acid with amoxicillin. Judicious drug use that includes defining the optimum dosage is important to control development of resistance to this drug combination. In this study, amoxicillin and clavulanic acid were administered to blue-fronted Amazon parrots (Amazona aestiva aestiva) in a multiple dosing trial. Birds were gavaged with 125 mg/kg of the drug combination at 0800, 1600, and 2200 hours on days 1–5. The half-lives of amoxicillin and clavulanic acid were similar to those in humans; however, the area under the curve was increased in the parrots compared with humans. These results suggest that this drug combination, at this dosing interval, achieves levels that may be effective against many bacterial species.
You have requested a machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Neither BioOne nor the owners and publishers of the content make, and they explicitly disclaim, any express or implied representations or warranties of any kind, including, without limitation, representations and warranties as to the functionality of the translation feature or the accuracy or completeness of the translations.
Translations are not retained in our system. Your use of this feature and the translations is subject to all use restrictions contained in the Terms and Conditions of Use of the BioOne website.
Vol. 14 • No. 2